BHC241129P7000
- 0.33
- 0.000.00%
Bausch Health Newsroom
Bausch Health Companies Inc. (NYSE:BHC) Is Favoured by Institutional Owners Who Hold 56% of the Company
Canadian Stock Movers for Wednesday | Hut 8 Corp Was the Top Gainer; Personal Services Led Gains
Bausch Health Put Volume Heavy and Directionally Bearish
Bausch (BHC) Upgraded to Buy: Here's What You Should Know
Bausch Health Announces CABTREO Receives Positive Reimbursement Recommendations
PrCABTREOTM (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide Gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations From Canada's Drug Agency and Quebec's INESSS
Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis
US Manufacturing Index Rises To 43, Highest Since 2020
Express News | Icahn Enterprises Discloses 9% Ownership Stake in Bausch Health Companies as of Sept 30 - Presentation
Alembic Pharmaceuticals Gets Final US FDA Nod for Diltiazem Hydrochloride Capsules
Bausch Health Companies Inc.'s (NYSE:BHC) Path To Profitability
Why Bausch Health (BHC) Is a Top Momentum Stock for the Long-Term
Bausch Health Companies Shares Are Trading Higher After RBC Capital Raised Its Price Target on the Stock From $10 to $11.
RBC on Bausch Health's Q3
Apple To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday
Bausch Health Companies Analyst Ratings
A Quick Look at Today's Ratings for Bausch Health(BHC.US), With a Forecast Between $3 to $12
RBC Lifts Price Target on Bausch Health to $11 From $10, Keeps Sector Perform Rating
Canadian Stock Movers for Friday | Aecon Group Inc Was the Top Gainer; Media-Diversified Led Gains
Bausch Health Options Spot-On: On October 31st, 86,196 Contracts Were Traded, With 303.29K Open Interest